ARID3B expression in primary breast cancers and breast cancer-derived cell lines

Cellular Oncology

Volumn 37, Issue 4, 2014, Pages 289-296

  Oguz Erdogan, Ayse Selcen ^a,b   Ozdemirler, Nihan ^a   Oyken, Merve ^a   Alper, Murat ^b   Erson Bensan, Ayse Elif ^a  

^a MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

^b DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

ARID3B expression; Breast cancer; ERBB2; Estrogen receptor

Indexed keywords

AT RICH INTERACTION DOMAIN 3; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ARID3B PROTEIN, HUMAN; DNA BINDING PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MITOSIS INDEX; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; BREAST TUMOR; GENETICS; IN VITRO STUDY; METABOLISM; MIDDLE AGED; TUMOR CELL LINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN VITRO TECHNIQUES; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84906936712     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-014-0185-5     Document Type: Article

References (22)

1. D. Wilsker, A. Patsialou, P.B. Dallas, E. Moran, ARID proteins: a diverse family of DNA binding proteins implicated in the control of cell growth, differentiation, and development. Cell Growth Differ. 13, 95-106 (2002)
2. C. Lin, W. Song, X. Bi, J. Zhao, Z. Huang, Z. Li, J. Zhou, J. Cai, H. Zhao, Recent advances in the ARID family: focusing on roles in human cancer. Oncol. Targets Ther. 7, 315-324 (2014)
3. S. Numata, P.P. Claudio, C. Dean, A. Giordano, C.M. Croce, Bdp, a new member of a family of DNA-binding proteins, associates with the retinoblastoma gene product. Cancer Res. 59, 3741-3747 (1999)
4. K. Kobayashi, T. Era, A. Takebe, L.M. Jakt, S. Nishikawa, ARID3B induces malignant transformation of mouse embryonic fibroblasts and is strongly associated with malignant neuroblastoma. Cancer Res. 66, 8331-8336 (2006)
5. J.C. Casanova, V. Uribe, C. Badia-Careaga, G. Giovinazzo, M. Torres, J.J. Sanz-Ezquerro, Apical ectodermal ridge morphogenesis in limb development is controlled by Arid3b-mediated regulation of cell movements. Development 138, 1195-1205 (2011)
6. P.L. Magoulas, A.W. El-Hattab, Chromosome 15q24 microdeletion syndrome. Orphanet J. Rare Dis. 7, 2 (2012)
7. K.D. Cowden Dahl, R. Dahl, J.N. Kruichak, L.G. Hudson, The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells. Neoplasia 11, 1208-1215 (2009)
8. S. Akhavantabasi, A. Sapmaz, S. Tuna, A.E. Erson-Bensan, miR-125b targets ARID3B in breast cancer cells. Cell Struct. Funct. 37, 27-38 (2009)
9. A. Erson, E. Petty, miRNAs and cancer: new research developments and potential clinical applications. Cancer Biol. Ther. 8, 2317-2322 (2009)
10. R. Nagadia, P. Pandit, W.B. Coman, J. Cooper-White, C. Punyadeera, miRNAs in head and neck cancer revisited. Cell. Oncol. (Dordr.) 36, 1-7 (2013)
11. E. Yiannakopoulou, Targeting epigenetic mechanisms and microRNAs by aspirin and other non steroidal anti-inflammatory agents - implications for cancer treatment and chemoprevention. Cell. Oncol. (Dordr.) 37, 167-178 (2014)
12. S. Garritano, A. Inga, F. Gemignani, S. Landi, More targets, more pathways and more clues for mutant p53. Oncogenesis 2, e54 (2013)
13. K. Kobayashi, L.M. Jakt, S.I. Nishikawa, Epigenetic regulation of the neuroblastoma genes, Arid3b and Mycn. Oncogene 32, 2640-2648 (2013)
14. S. Joseph, V.E. Deneke, K.D. Cowden Dahl, ARID3B induces tumor necrosis factor alpha mediated apoptosis while a novel ARID3B splice form does not induce cell death. PLoS One 7, e42159 (2012)
15. B.H. Akman, T. Can, A.E. Erson-Bensan, Estrogen-induced upregulation and 3′-UTR shortening of CDC6. Nucleic Acids Res. 40, 10679-10688 (2012)
16. S. Akhavantabasi, H.B. Akman, A. Sapmaz, J.Keller, E.M. Petty, A.E. Erson, USP32 is an active, membrane-bound ubiquitin protease overexpressed in breast cancers. Mamm. Genome 21, 388-397 (2010)
17. W.J. Kent, C.W. Sugnet, T.S. Furey, K.M. Roskin, T.H. Pringle, A.M. Zahler, D. Haussler, The human genome browser at UCSC. Genome Res. 12, 996-1006 (2002)
18. R. Metivier, G. Penot, R.P. Carmouche, M.R. Hubner, G. Reid, S. Denger, D. Manu, H. Brand, M. Kos, V. Benes, F. Gannon, Transcriptional complexes engaged by apo-estrogen receptor-alpha isoforms have divergent outcomes. EMBO J. 23, 3653-3666 (2004)
19. D. McDonald, G. Carrero, C. Andrin, G. de Vries, M.J. Hendzel, Nucleoplasmic beta-actin exists in a dynamic equilibrium between low-mobility polymeric species and rapidly diffusing populations. J. Cell Biol. 172, 541-552 (2006)
20. L.A. Carey, C.M. Perou, C.A. Livasy, L.G. Dressler, D. Cowan, K. Conway, G. Karaca, M.A. Troester, C.K. Tse, S. Edmiston, S.L. Deming, J. Geradts, M.C. Cheang, T.O. Nielsen, P.G. Moorman, H.S. Earp, R.C. Millikan, Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295, 2492-2502 (2006)
21. G. Scott, A. Goga, D. Bhaumik, C. Berger, C. Sullivan, C. Benz, Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J. Biol. Chem. 282, 1479-1486 (2007)
22. S.J. Samyesudhas, L. Roy, K.D. Cowden Dahl, Differential expression of ARID3B in normal adult tissue and carcinomas. Gene 10, 174-180 (2014)